Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Net Income: 2009-2025

Historic Net Income for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to -$1.1 million.

  • Lifecore Biomedical's Net Income fell 38333.33% to -$1.1 million in Q2 2025 from the same period last year, while for May 2025 it was -$38.7 million, marking a year-over-year decrease of 1543.59%. This contributed to the annual value of -$38.7 million for FY2025, which is 1543.59% down from last year.
  • According to the latest figures from Q2 2025, Lifecore Biomedical's Net Income is -$1.1 million, which was up 92.23% from -$14.8 million recorded in Q1 2025.
  • Lifecore Biomedical's 5-year Net Income high stood at $1.9 million for Q3 2023, and its period low was -$51.6 million during Q2 2022.
  • Its 3-year average for Net Income is -$6.3 million, with a median of -$1.7 million in 2023.
  • Its Net Income has fluctuated over the past 5 years, first spiked by 143.58% in 2023, then slumped by 38,333.33% in 2025.
  • Lifecore Biomedical's Net Income (Quarterly) stood at -$46.0 million in 2021, then soared by 92.17% to -$3.6 million in 2022, then spiked by 99.33% to -$24,000 in 2023, then slumped by 27,279.17% to -$6.6 million in 2024, then crashed by 38,333.33% to -$1.1 million in 2025.
  • Its Net Income was -$1.1 million in Q2 2025, compared to -$14.8 million in Q1 2025 and -$6.6 million in Q4 2024.